Background Irritable bowel syndrome (IBS) is one of the most common functional bowel
disorders, but community prevalence appears to vary widely between different countries …

Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …

Up to 20% of people worldwide develop gastrointestinal symptoms following a meal, leading
to decreased quality of life, substantial morbidity and high medical costs. Although the …

The term inflammatory bowel disease (IBD) refers principally to two major categories of
chronic relapsing inflammatory intestinal disorders: Crohn's disease (CD) and ulcerative …

Inflammatory bowel disease (IBD) is a chronic relapsing–remitting systemic disease of the
gastrointestinal tract, characterized by an inflammatory process that requires lifelong …

Managing irritable bowel syndrome (IBS) has attracted international attention because
single-agent therapy rarely relieves bothersome symptoms for all patients. The Japanese …

Importance Irritable bowel syndrome (IBS) affects 7% to 21% of the general population. It is
a chronic condition that can substantially reduce quality of life and work productivity …

Traditionally, irritable bowel syndrome has been considered to be a disorder with no known
underlying structural or biochemical explanation, but this concept is likely to be outdated. In …

Background Patients with inflammatory bowel disease (IBD) often report symptoms
compatible with irritable bowel syndrome (IBS), which might have an effect on psychological …

Irritable bowel syndrome (IBS) is a complex, functional gastrointestinal disorder
characterized by chronic abdominal pain or discomfort and altered bowel habits. Despite the …